Population Pharmacokinetics of Elagolix in Combination with Low-Dose Estradiol/Norethindrone Acetate in Women with Uterine Fibroids

BACKGROUND AND OBJECTIVES: Elagolix is an orally active, gonadotropin-releasing hormone receptor antagonist approved for the management of endometriosis-associated pain and heavy menstrual bleeding associated with uterine fibroids. Elagolix population pharmacokinetics and factors affecting elagolix...

Descripción completa

Detalles Bibliográficos
Autores principales: Beck, Denise, Winzenborg, Insa, Liu, Mohan, Degner, Jacob, Mostafa, Nael M., Noertersheuser, Peter, Shebley, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975762/
https://www.ncbi.nlm.nih.gov/pubmed/34878624
http://dx.doi.org/10.1007/s40262-021-01096-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975762/
https://www.ncbi.nlm.nih.gov/pubmed/34878624
http://dx.doi.org/10.1007/s40262-021-01096-w

Ejemplares similares